Ostatní
Návod 
EyePoint Pharmaceuticals, Inc.
EYPT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.8B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-103%
ROA
-82%
PE
-5
PS
35
Cena 1R
4-19
⌀ Cena
11.24
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-03-2026
Poslední dividenda
Profil
EyePoint Pharmaceuticals, Inc., farmaceutická společnost, vyvíjí a komercializuje oční přípravky pro léčbu očních onemocnění ve Spojených státech, Číně a Velké Británii. Společnost poskytuje ILUVIEN, injekčně podávanou mikrovložku s prodlouženým uvolňováním k léčbě diabetického makulárního edému; YUTIQ, intravitreální implantát fluokinolonacetonidu k léčbě intravitreální injekce k léčbě chronické neinfekční uveitidy postihující zadní část oka; a DEXYCU, intraokulární suspenzi dexamethazonu, k léčbě pooperačního zánětu oka, včetně léčby po operaci katarakty. Vyvíjí se také EYP- 1901, bioerodiblická léková forma inhibitoru tyrosinkinázy dvakrát ročně pro léčbu makulární degenerace související s věkem ve vlhkém prostředí, diabetické retinopatie a okluze sítnicové žíly; a YUTIQ50 pro léčbu chronické neinfekční uveitidy postihující zadní část oka. Společnost strategicky spolupracuje se společnostmi Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics a Equinox Science, LLC. Má také obchodní spojenectví s ImprimisRx PA, Inc. pro společnou propagaci DEXYCU pro léčbu pooperačního zánětu po operaci oka. Společnost byla dříve známá jako Sivida Corp. a v březnu 2018 změnila svůj název na EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc. byla založena v roce 1987 a sídlí ve Watertownu v Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
165
Založení
2005-01-27
Podobné společnosti
$ 2.77
- $ 0.12
$ 10.29
+ $ 0.43
$ 18.44
+ $ 0.81
$ 7.87
- $ 0.01
$ 3.67
- $ 0.15
$ 3.97
+ $ 0.02
$ 12.41
+ $ 0.10
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 31.4 | 31.4 | 43.3 | 46.0 | 41.4 | 36.9 | 34.4 | 20.4 | 3.0 | 7.5 | 1.6 | 26.6 | 3.5 | 2.1 | 3.5 | 5.0 | 23.1 | |
| Cost of Revenues | 2.1 | 2.1 | 3.7 | 4.6 | 8.3 | 8.2 | 5.8 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 29.3 | 29.3 | 39.6 | 41.4 | 33.1 | 28.8 | 28.6 | 17.7 | 3.0 | 7.5 | 1.6 | 26.6 | 3.4 | 2.1 | 3.5 | 5.0 | 23.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.6 | 1.0 | 5.3 | 24.5 | 11.6 | 10.5 | 9.5 | 11.7 | 14.0 | 15.2 | |
| Cost of Revenues | 0.4 | 0.7 | 0.2 | 0.8 | 0.8 | 0.7 | 1.4 | 0.8 | 1.0 | 1.2 | |
| Gross Profit | 0.2 | 0.2 | 5.2 | 23.6 | 10.8 | 9.8 | 8.1 | 10.9 | 13.0 | 14.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 64.7 | 49.6 | 28.5 | 17.4 | 15.4 | 16.2 | 14.9 | 14.4 | 12.1 | 9.6 | 7.0 | 7.0 | 6.9 | 7.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 51.8 | 60.3 | 53.1 | 46.0 | 47.7 | 13.1 | 11.2 | 9.0 | 8.1 | 7.5 | 7.2 | 6.9 | 8.1 | 7.0 | |
| Depreciation & Amortization | 1.6 | 0.0 | 1.5 | 0.5 | 4.2 | 2.8 | 2.5 | 3.5 | 1.1 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 2.2 | 3.4 | 3.3 | |
| Total Operating Expenses | 272.7 | 272.7 | 185.4 | 115.0 | 112.0 | 84.0 | 65.9 | 65.5 | 29.2 | 26.1 | 23.4 | 20.1 | 17.0 | 14.2 | 13.9 | 15.0 | 14.0 | |
| Operating Income | -243.4 | -243.4 | -145.9 | -75.1 | -78.9 | -55.3 | -37.3 | -47.9 | -26.3 | -18.6 | -21.8 | 6.4 | -13.5 | -12.0 | -25.2 | -10.0 | 9.1 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.0 | 17.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.4 | 11.0 | ||
| Depreciation & Amortization | 0.0 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.1 | 0.1 | ||
| Total Operating Expenses | 70.6 | 62.3 | 67.4 | 72.5 | 56.0 | 42.5 | 42.6 | 44.2 | 29.4 | 28.4 | ||
| Operating Income | -70.3 | -62.0 | -62.2 | -48.8 | -45.2 | -32.7 | -34.5 | -33.3 | -16.4 | -14.4 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 11.8 | 11.8 | 15.1 | 6.9 | 2.1 | 0.3 | 0.1 | 1.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 1.2 | 3.2 | 5.5 | 7.3 | 6.2 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 11.8 | 11.8 | 15.1 | 4.4 | -23.3 | -3.1 | -8.1 | -8.9 | -26.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | -14.7 | 1.1 | -0.3 | |
| IBT | -231.7 | -231.7 | -130.8 | -70.7 | -102.3 | -58.4 | -45.4 | -56.8 | -53.2 | -18.5 | -21.7 | 6.4 | -13.5 | -12.0 | -25.0 | -8.8 | 8.8 | |
| Income Tax Expense | -0.1 | 0.3 | 0.1 | 0.1 | 22.3 | 5.5 | 7.3 | 6.2 | -25.6 | -0.8 | -0.2 | 0.1 | -0.1 | -0.1 | -0.2 | -0.2 | 0.0 | |
| Net Income | -232.0 | -232.0 | -130.9 | -70.8 | -124.5 | -63.9 | -52.7 | -63.0 | -53.2 | -18.5 | -21.5 | 6.3 | -13.4 | -11.9 | -24.8 | -8.6 | 8.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.9 | 2.3 | 2.9 | 3.6 | 3.9 | 3.4 | 3.7 | 4.0 | 2.3 | 1.8 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | 2.9 | 2.3 | 2.9 | 3.6 | 3.9 | 3.4 | 3.7 | 4.0 | 2.3 | 1.8 | ||
| IBT | -67.4 | -59.7 | -59.3 | -45.2 | -41.3 | -29.4 | -30.8 | -29.3 | -14.0 | -12.6 | ||
| Income Tax Expense | -0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 1.8 | ||
| Net Income | -67.6 | -59.7 | -59.4 | -45.2 | -41.4 | -29.4 | -30.8 | -29.3 | -14.1 | -12.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.82 | $-3.34 | $-2.22 | $-4.10 | $-6.04 | $-11.50 | $-5.23 | $-6.81 | $2.20 | $-4.87 | $-5.16 | $-11.95 | $-4.43 | $4.80 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.82 | $-3.34 | $-2.22 | $-4.10 | $-6.04 | $-11.50 | $-5.23 | $-6.81 | $2.10 | $-4.87 | $-5.16 | $-11.95 | $-4.43 | $4.60 | |
| Shares Outstanding | 83.0 | 73.3 | 56.3 | 38.9 | 37.3 | 28.8 | 12.8 | 10.4 | 4.6 | 3.5 | 3.2 | 2.9 | 2.7 | 2.3 | 2.1 | 1.9 | 1.8 | |
| Diluted Shares Outstanding | 83.0 | 73.3 | 56.3 | 38.9 | 37.3 | 28.8 | 12.8 | 10.4 | 4.6 | 3.5 | 3.2 | 3.1 | 2.7 | 2.3 | 2.1 | 1.9 | 1.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.33 | $-0.33 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.33 | $-0.33 | ||
| Shares Outstanding | 83.0 | 70.2 | 69.9 | 69.8 | 64.6 | 54.4 | 53.2 | 52.9 | 42.2 | 38.3 | ||
| Diluted Shares Outstanding | 83.0 | 70.2 | 69.9 | 69.8 | 64.6 | 54.4 | 53.2 | 52.9 | 42.2 | 38.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 90.8 | 99.7 | 281.3 | 95.6 | 178.6 | 44.9 | 22.2 | 38.8 | 16.9 | 15.3 | 19.1 | 15.3 | 6.9 | 4.6 | 12.9 | 15.5 | |
| Short Term Investments | 189.5 | 271.2 | 49.8 | 48.9 | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.7 | 9.4 | 2.9 | 3.4 | 9.9 | 11.2 | 2.1 | |
| Total Cash & ST Investments | 280.2 | 370.9 | 331.1 | 144.6 | 211.6 | 44.9 | 22.2 | 38.8 | 16.9 | 29.0 | 28.5 | 18.3 | 10.3 | 14.6 | 24.1 | 17.6 | |
| Accounts Receivable | 1.4 | 0.6 | 0.8 | 15.5 | 18.4 | 9.5 | 11.7 | 0.4 | 0.3 | 0.5 | 0.6 | 0.5 | 0.6 | 1.0 | 0.8 | 1.1 | |
| Inventory | 3.7 | 2.3 | 3.9 | 2.9 | 3.6 | 5.3 | 2.1 | -0.4 | -0.3 | -0.5 | -0.6 | 0.0 | -0.6 | -1.0 | -0.8 | -1.1 | |
| Other Current Assets | 9.6 | 9.5 | 9.0 | 9.9 | 4.2 | 3.4 | 8.1 | 1.1 | 0.8 | 1.0 | 1.3 | 0.5 | 2.2 | 1.4 | 1.2 | 1.5 | |
| Total Current Assets | 294.9 | 383.3 | 344.8 | 172.8 | 237.7 | 63.1 | 42.1 | 39.9 | 17.7 | 30.0 | 29.8 | 19.3 | 12.5 | 16.0 | 25.4 | 19.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 74.6 | 71.1 | 85.2 | 99.7 | 79.8 | 90.8 | 271.0 | 281.3 | 133.0 | 139.6 | |
| Short Term Investments | 129.4 | 184.6 | 233.0 | 271.2 | 174.0 | 189.5 | 28.3 | 49.8 | 3.0 | 2.9 | |
| Total Cash & ST Investments | 204.0 | 255.7 | 318.2 | 370.9 | 253.8 | 280.2 | 299.3 | 331.1 | 136.0 | 142.5 | |
| Accounts Receivable | 1.0 | 0.6 | 0.4 | 0.6 | 0.4 | 1.4 | 3.0 | 0.8 | 0.5 | 11.0 | |
| Inventory | 2.1 | 2.7 | 2.1 | 2.3 | 2.8 | 3.7 | 4.3 | 3.9 | 4.6 | 4.3 | |
| Other Current Assets | 8.9 | 6.2 | 6.2 | 9.5 | 11.6 | 9.6 | 11.1 | 9.0 | 9.1 | 9.4 | |
| Total Current Assets | 216.1 | 265.3 | 327.0 | 383.3 | 268.5 | 294.9 | 317.7 | 344.8 | 150.2 | 167.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 29.2 | 29.2 | 10.2 | 6.0 | 2.3 | 3.2 | 3.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.1 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 22.7 | 25.2 | 27.7 | 31.4 | 0.4 | 1.1 | 1.9 | 2.8 | 3.4 | 4.2 | 21.6 | 23.9 | |
| Long-Term Investments | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.0 | 6.0 | 0.0 | 1.5 | 0.6 | 0.2 | 0.5 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Total Long-Term Assets | 29.3 | 35.2 | 10.4 | 7.5 | 25.6 | 28.6 | 31.3 | 31.8 | 0.9 | 1.7 | 2.5 | 3.3 | 3.8 | 4.6 | 21.7 | 24.0 | |
| Total Assets | 324.2 | 418.5 | 355.2 | 180.4 | 263.4 | 91.7 | 73.3 | 71.7 | 18.7 | 31.6 | 32.4 | 22.7 | 16.2 | 20.6 | 47.1 | 43.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 29.5 | 21.1 | 29.6 | 29.2 | 29.8 | 29.2 | 11.4 | 10.2 | 5.3 | 5.5 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Other Long-Term Assets | 6.1 | 14.8 | 6.0 | 6.0 | 2.6 | 0.2 | 0.0 | 0.0 | 4.5 | 2.9 | |
| Total Long-Term Assets | 35.6 | 35.9 | 35.6 | 35.2 | 32.4 | 29.3 | 11.5 | 10.4 | 9.9 | 8.5 | |
| Total Assets | 251.7 | 301.1 | 362.6 | 418.5 | 300.9 | 324.2 | 329.2 | 355.2 | 160.0 | 175.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 14.3 | 11.7 | 6.5 | 5.9 | 7.4 | 4.8 | 11.4 | 6.7 | 1.0 | 1.4 | 0.7 | 0.5 | 0.7 | 0.4 | 0.3 | 0.4 | |
| Short-Term Debt | 1.1 | 0.0 | 0.0 | 10.5 | 0.8 | 8.4 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.2 | |
| Other Current Liabilities | 13.3 | 19.5 | 18.2 | 16.9 | 14.4 | 0.7 | 0.0 | 15.0 | 4.2 | 3.6 | 2.6 | 1.5 | 1.9 | 0.6 | 0.2 | 1.3 | |
| Current Liabilities | 62.1 | 49.0 | 63.3 | 34.5 | 23.7 | 14.9 | 11.9 | 21.7 | 5.3 | 5.1 | 3.3 | 2.1 | 3.3 | 3.2 | 5.0 | 2.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 28.0 | 31.2 | 16.4 | 11.7 | 7.3 | 14.3 | 7.1 | 6.5 | 9.6 | 10.7 | |
| Short-Term Debt | 0.0 | 0.0 | 1.8 | 0.0 | 0.0 | 1.1 | 1.1 | 0.0 | 1.1 | 1.0 | |
| Other Current Liabilities | 2.1 | 2.0 | 18.4 | 19.5 | 15.5 | 13.3 | 16.0 | 18.2 | 13.4 | 15.1 | |
| Current Liabilities | 30.1 | 33.2 | 41.7 | 49.0 | 48.8 | 62.1 | 62.6 | 63.3 | 63.9 | 68.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 22.2 | 21.9 | 4.9 | 35.3 | 38.4 | 40.3 | 50.1 | 17.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 22.2 | 21.9 | 4.9 | 6.0 | 1.9 | 2.3 | 3.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | -11.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Total Liabilities | 95.9 | 82.0 | 88.9 | 84.0 | 79.0 | 73.2 | 65.0 | 60.0 | 5.3 | 10.7 | 9.0 | 7.7 | 8.5 | 7.0 | 9.7 | 10.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 21.3 | 21.8 | 22.3 | 21.9 | 21.9 | 22.2 | 4.6 | 4.9 | 5.2 | 5.5 | |
| Capital Leases | 21.3 | 21.8 | 24.1 | 21.9 | 21.9 | 23.3 | 4.6 | 4.9 | 5.2 | 5.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -20.7 | -32.3 | -44.0 | |
| Total Liabilities | 51.5 | 55.1 | 64.2 | 82.0 | 82.2 | 95.9 | 79.3 | 88.9 | 101.4 | 118.4 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.0 | 766.9 | 752.6 | 528.4 | 472.8 | 374.8 | 323.3 | 312.2 | 293.1 | 0.0 | 270.4 | 264.5 | 262.9 | 250.8 | |
| Retained Earnings | -802.3 | -873.0 | -742.1 | -671.4 | -569.1 | -510.7 | -465.3 | -364.0 | -310.8 | -292.2 | -270.7 | -277.0 | -263.7 | -251.8 | -226.9 | -218.3 | |
| Comprehensive Income | 0.8 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 | 0.9 | 0.9 | 1.4 | 0.5 | |
| Total Common Equity | 228.3 | 336.5 | 266.3 | 96.4 | 184.4 | 18.5 | 8.3 | 11.7 | 13.3 | 20.9 | 23.4 | 14.9 | 7.7 | 13.6 | 37.4 | 33.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 785.8 | 771.9 | |
| Retained Earnings | -1,037.4 | -977.6 | -918.2 | -873.0 | -831.6 | -802.3 | -771.4 | -742.1 | -728.0 | -715.4 | |
| Comprehensive Income | 0.9 | 0.8 | 0.9 | 1.0 | 1.2 | 0.8 | 0.8 | 0.9 | 0.8 | 0.8 | |
| Total Common Equity | 200.2 | 246.0 | 298.4 | 336.5 | 218.7 | 228.3 | 249.9 | 266.3 | 58.6 | 57.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 23.3 | 21.9 | 4.9 | 45.8 | 38.4 | 40.3 | 50.6 | 17.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 228.3 | 336.5 | 266.3 | 96.4 | 184.4 | 18.5 | 8.3 | 11.7 | 13.3 | 20.9 | 23.4 | 14.9 | 7.7 | 13.6 | 37.4 | 33.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 200.2 | 246.0 | 298.4 | 336.5 | 218.7 | 228.3 | 249.9 | 266.3 | 58.6 | 57.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -86.8 | -232.0 | -130.9 | -70.8 | -102.3 | -58.4 | -45.4 | -56.8 | -53.2 | -18.5 | -21.5 | 6.3 | -13.4 | -11.9 | -24.8 | -8.6 | 8.8 | |
| Depreciation & Amortization | 0.9 | 2.3 | 1.5 | 0.5 | 2.4 | 2.8 | 2.6 | 2.6 | 1.1 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 2.2 | 3.4 | 3.3 | |
| Stock-Based Compensation | 28.6 | 27.9 | 36.7 | 12.1 | 14.2 | 7.4 | 5.5 | 4.6 | 2.7 | 2.5 | 2.2 | 2.0 | 1.4 | 1.3 | 1.4 | 2.1 | 1.5 | |
| Change Working Capital | -29.6 | -33.8 | -27.8 | 58.9 | -3.0 | -1.7 | 20.1 | -12.5 | 0.9 | 0.3 | 2.1 | 1.0 | 0.4 | 0.7 | -2.7 | 1.2 | -4.0 | |
| Change In Accounts Receivable | 9.3 | -10.7 | -0.2 | 14.4 | -2.7 | -10.6 | 4.8 | -15.3 | 0.0 | 0.2 | 0.1 | -0.1 | 0.1 | 0.4 | -0.1 | 0.3 | -0.3 | |
| Change In Accounts Payable | 1.5 | 4.7 | 5.7 | 1.5 | 1.2 | 8.5 | 1.9 | 4.6 | 1.7 | -0.3 | 0.6 | 0.3 | -0.2 | 0.3 | 0.1 | -0.1 | 0.1 | |
| Change In Inventories | 0.6 | 0.5 | 1.6 | -1.6 | -0.8 | 1.3 | -3.2 | -1.9 | -0.8 | 0.6 | 1.2 | 0.9 | 0.7 | 0.0 | -0.8 | 0.1 | -0.3 | |
| Other Non-cash Items | 13.5 | -4.8 | -6.0 | 1.2 | 23.6 | 0.6 | 1.7 | 1.6 | 0.2 | -5.6 | 0.1 | 0.1 | 0.0 | 0.2 | 14.9 | -1.0 | 0.3 | |
| Cash from Operations | -89.7 | 0.0 | 0.0 | 1.9 | -65.0 | -50.1 | -14.4 | -56.7 | -21.9 | -20.5 | -16.3 | 10.3 | -10.7 | -8.7 | -9.0 | -3.2 | 9.9 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -67.6 | -59.7 | -59.4 | -45.2 | -41.4 | -29.4 | -30.8 | -29.3 | -14.1 | -12.6 | |
| Depreciation & Amortization | 0.7 | 0.6 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.1 | 0.1 | |
| Stock-Based Compensation | 6.7 | 6.4 | 6.9 | 7.8 | 7.9 | 7.4 | 8.7 | 12.7 | 3.6 | 3.6 | |
| Change Working Capital | -4.3 | -5.7 | -9.3 | -14.5 | -1.1 | 11.0 | 3.3 | -14.3 | -12.3 | -6.3 | |
| Change In Accounts Receivable | -10.8 | -3.1 | -0.2 | 3.4 | 1.9 | -0.9 | 3.1 | -4.3 | -0.3 | 10.7 | |
| Change In Accounts Payable | 6.2 | -3.1 | -3.5 | 5.0 | 8.1 | -6.0 | 5.1 | -1.4 | 0.7 | -2.9 | |
| Change In Inventories | 0.3 | 0.6 | -0.5 | 0.2 | 0.5 | 0.9 | 0.6 | -0.4 | 0.7 | -0.3 | |
| Other Non-cash Items | -1.0 | -0.9 | -1.3 | -1.7 | -1.7 | -28.6 | -1.7 | -0.6 | -0.5 | -3.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.1 | -15.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.7 | -3.3 | -4.1 | -3.5 | -2.2 | -0.2 | -0.4 | -0.2 | -0.1 | -0.1 | -0.1 | -0.2 | -0.2 | -0.1 | -0.4 | -0.1 | 0.0 | |
| Acquisitions | 46.3 | 0.2 | 0.0 | -0.2 | -0.6 | 0.0 | 0.0 | 0.0 | -16.8 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -234.3 | -252.0 | -398.3 | -55.1 | -139.1 | -33.0 | 0.0 | 0.0 | 0.0 | -5.1 | -17.5 | -10.2 | -3.0 | -7.8 | -15.4 | -16.0 | -2.1 | |
| Sales of Investment | 50.5 | 318.9 | 177.0 | 55.3 | 124.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.7 | 13.2 | 3.7 | 3.4 | 14.2 | 16.4 | 6.6 | 0.0 | |
| Other Investing Activities | -24.3 | 0.0 | 0.0 | 0.2 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -188.5 | 0.0 | 0.0 | -3.3 | -17.3 | -33.1 | -0.4 | -0.2 | -16.9 | 13.6 | -4.5 | -6.7 | 0.1 | 6.4 | 0.6 | -9.5 | -2.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.0 | -0.8 | -1.2 | -0.3 | -0.4 | -1.6 | -0.9 | -1.2 | -0.9 | -1.7 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 46.3 | 0.0 | |
| Investments | -148.8 | -9.8 | -53.9 | -39.4 | -164.1 | -49.2 | -185.0 | 0.0 | -49.3 | 0.0 | |
| Sales of Investment | 78.7 | 62.1 | 103.5 | 79.2 | 68.5 | 62.9 | 25.5 | 22.0 | 3.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -46.3 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -47.1 | -1.7 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -2.7 | 0.0 | 0.0 | -40.5 | -71.8 | -0.1 | -13.8 | -20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 20.5 | 21.9 | 17.0 | -0.4 | 79.1 | -1.7 | 3.5 | 53.3 | 17.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 234.5 | 0.0 | 0.0 | 226.2 | 0.4 | 216.8 | 49.9 | 22.6 | 41.5 | 8.4 | 16.5 | 0.0 | 18.1 | 4.7 | 0.0 | 10.0 | 0.0 | |
| Repurchase of Common Stock | -4.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -5.2 | 0.0 | 0.0 | 1.4 | 70.7 | 0.2 | 1.4 | 31.2 | 19.2 | 0.1 | 0.5 | 0.2 | 1.0 | 0.0 | 0.1 | 0.0 | 0.8 | |
| Cash from Financing | 229.3 | 0.0 | 0.0 | 187.1 | -0.7 | 216.9 | 37.5 | 33.9 | 60.7 | 8.5 | 17.0 | 0.2 | 19.0 | 4.7 | 0.1 | 10.1 | 0.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 21.3 | -0.5 | -2.3 | 2.2 | -0.1 | -1.4 | 17.6 | 0.3 | 0.3 | -0.3 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 216.2 | 10.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 10.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 218.5 | 10.4 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -48.8 | 2.1 | -181.6 | 185.6 | -83.0 | 133.7 | 22.7 | -23.0 | 21.9 | 1.6 | -3.8 | 3.8 | 8.4 | 2.3 | -8.3 | -2.6 | 8.6 | |
| Closing Cash Balance | 90.8 | 102.0 | 99.9 | 281.3 | 95.8 | 178.7 | 45.1 | 22.4 | 38.9 | 16.9 | 15.3 | 19.1 | 15.3 | 6.9 | 4.6 | 12.9 | 15.5 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 27.2 | 3.4 | -14.0 | -14.5 | 19.9 | -10.9 | -180.2 | -10.3 | 148.2 | -6.6 | |
| Closing Cash Balance | 102.0 | 74.7 | 71.3 | 85.2 | 99.9 | 80.0 | 90.8 | 271.0 | 281.3 | 133.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -94.4 | -243.4 | -130.3 | -1.6 | -67.2 | -50.3 | -14.8 | -56.9 | -22.0 | -20.6 | -16.4 | 10.1 | -10.9 | -8.8 | -9.4 | -3.3 | 9.9 | |
| Real Free Cash Flow | -123.0 | -271.3 | -167.0 | -13.7 | -81.3 | -57.7 | -20.3 | -61.5 | -24.7 | -23.1 | -18.6 | 8.2 | -12.3 | -10.1 | -10.8 | -5.4 | 8.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -66.0 | -60.2 | -63.8 | -53.4 | -36.2 | -40.6 | -21.1 | -32.4 | -24.0 | -16.9 | |
| Real Free Cash Flow | -72.8 | -66.6 | -70.7 | -61.2 | -44.1 | -48.0 | -29.8 | -45.1 | -27.6 | -20.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -4.7 | -3.8 | -1.4 |
| P/S | 35 | 15 | 9.4 |
| P/B | 5.5 | 5.7 | 5.2 |
| P/FCF | -4 | 31.6 | -1.5 |
| Market cap | $0.8 | $0.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 8.5 % | 13.1 % | 0 % |
| Debt to Income | -9.2 % | -24.2 % | 0 % |
| Debt to Free cash flow | -7.9 % | -116.1 % | 0 % |
| Interest expense percentage | 0 % | -3.5 % | 44.7 % |
| Current ratio | 7.2 | 6.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -115.9 % | -149.8 % | 0 % |
| ROA | -92.2 % | -54.8 % | 0 % |
| CapEx to Revenue | 6.3 % | 3.9 % | 0 % |
| RaD to Revenue | 0 % | 239.3 % | 0 % |
| ROEM | 190,133.3 | 252250.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 94.1 % | 94 % | 68.7 % |
| Operating margin | -515.7 % | -400.3 % | 35.5 % |
| Net margin | -486 % | -479.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 70.2 mil | 16.3 mil |
| Employee count | 0.2 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
